Supernus Pharmaceuticals Inc
SWB:S49
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Supernus Pharmaceuticals Inc
SWB:S49
|
US |
|
L
|
Lumentum Holdings Inc
DUS:LU2
|
US |
|
T
|
Terumo Corp
SWB:TUO
|
JP |
|
C
|
CBRE Group Inc
DUS:RF6
|
US |
|
T
|
Tencent Holdings Ltd
XBER:NNND
|
CN |
|
L
|
Laurent Perrier SA
SWB:LPE
|
FR |
|
G
|
Grenergy Renovables SA
MAD:GRE
|
ES |
|
L
|
Lumentum Holdings Inc
F:LU2
|
US |
|
M
|
Microsoft Corp
XMUN:MSF
|
US |
|
Netcare Ltd
OTC:NWKHY
|
ZA |
Dividends
Dividend Yield
Supernus Pharmaceuticals Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Supernus Pharmaceuticals Inc
S49 have decreased by 0%.
Payout Ratio
Supernus Pharmaceuticals Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for S49 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
S49 Price
Supernus Pharmaceuticals Inc
| Average Annual Return | 11.83% |
| Standard Deviation of Annual Returns | 26.3% |
| Max Drawdown | -26% |
| Market Capitalization | 2.7B EUR |
| Shares Outstanding | 54 965 316 |
| Percentage of Shares Shorted |
N/A
|
